Kelly Shaffer
Impact in
-
- Metabolism and Genetic Disorders
-
- Mitochondrial Function and Pathology
- ATP Synthase and ATPases Research
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- Renal and related cancers
Papers in
-
- Electrolyte and hormonal disorders 1
-
- Viral Infections and Outbreaks Research 2
- Co-authors
- R.M. Voorhees (1 shared paper)Brett Lomenick (1 shared paper)Jonathan S. Weissman (1 shared paper)Tsui‐Fen Chou (1 shared paper)Taylor A. Stevens (1 shared paper)Angela N. Pogson (1 shared paper)Alison J. Inglis (1 shared paper)Joseph M. Replogle (1 shared paper)
- Journals
- PLoS neglected tropical diseases (1 paper)Therapeutics and Clinical Risk Management (1 paper)JCI Insight (1 paper)Science (1 paper)Expert Review of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesNetherlandsDemocratic Republic of the Congo
In The Last Decade
Kelly Shaffer
7 papers receiving 138 citations
Peers
Comparison fields: 5 of 46
- Clinical Biochemistry 14
- Molecular Biology 100
- Cell Biology 18
- Nephrology 7
- Genetics 26
Countries citing papers authored by Kelly Shaffer
This map shows the geographic impact of Kelly Shaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Shaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Shaffer more than expected).
Fields of papers citing papers by Kelly Shaffer
This network shows the impact of papers produced by Kelly Shaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Shaffer. The network helps show where Kelly Shaffer may publish in the future.
Co-authors
The 25 scholars most cited alongside Kelly Shaffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 87 | |
| 2 | 2019 | 22 | |
| 3 | 2022 | 17 | |
| 4 | 2022 | 6 | |
| 5 | 2019 | 4 | |
| 6 | 2021 | 3 | |
| 7 | 2025 | 1 |
About Kelly Shaffer
Kelly Shaffer is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Molecular Biology, Nephrology and Epidemiology, having authored 7 papers that have together received 140 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (2 papers), Viral Infections and Outbreaks Research (2 papers), Metabolism and Genetic Disorders (1 paper), Genetic and Kidney Cyst Diseases (1 paper), Bipolar Disorder and Treatment (1 paper), Renal and related cancers (1 paper), Electrolyte and hormonal disorders (1 paper) and Parathyroid Disorders and Treatments (1 paper). The work is most often cited by research in Clinical Biochemistry (14 citations), Molecular Biology (100 citations), Cell Biology (18 citations), Nephrology (7 citations) and Genetics (26 citations). Kelly Shaffer has collaborated with scholars based in United States, Netherlands and Democratic Republic of the Congo. Frequent co-authors include R.M. Voorhees, Brett Lomenick, Jonathan S. Weissman, Tsui‐Fen Chou, Taylor A. Stevens, Angela N. Pogson, Alison J. Inglis, Joseph M. Replogle, Alina Guna and Anjay Rastogi. Their work appears in journals such as PLoS neglected tropical diseases, Therapeutics and Clinical Risk Management, JCI Insight, Science and Expert Review of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.